Efficacy and Safety of Combination Therapies With Oseltamivir and Zanamivir or Oseltamivir and Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection.

Trial Profile

Efficacy and Safety of Combination Therapies With Oseltamivir and Zanamivir or Oseltamivir and Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2012

At a glance

  • Drugs Amantadine (Primary) ; Oseltamivir (Primary) ; Zanamivir (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 31 Jan 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top